Cargando…
Channel Openings Are Necessary but not Sufficient for Use-dependent Block of Cardiac Na(+) Channels by Flecainide: Evidence from the Analysis of Disease-linked Mutations
Na(+) channel blockers such as flecainide have found renewed usefulness in the diagnosis and treatment of two clinical syndromes arising from inherited mutations in SCN5A, the gene encoding the α subunit of the cardiac voltage–gated Na(+) channel. The Brugada syndrome (BrS) and the LQT-3 variant of...
Autores principales: | Liu, Huajun, Tateyama, Michihiro, Clancy, Colleen E., Abriel, Hugues, Kass, Robert S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311398/ https://www.ncbi.nlm.nih.gov/pubmed/12084774 http://dx.doi.org/10.1085/jgp.20028558 |
Ejemplares similares
-
Common Molecular Determinants of Flecainide and Lidocaine Block of Heart Na(+) Channels: Evidence from Experiments with Neutral and Quaternary Flecainide Analogues
por: Liu, Huajun, et al.
Publicado: (2003) -
State-dependent Block of Wild-type and Inactivation-deficient Na(+) Channels by Flecainide
por: Wang, Ging Kuo, et al.
Publicado: (2003) -
The Na(+) Channel Inactivation Gate Is a Molecular Complex: A Novel Role of the COOH-terminal Domain
por: Motoike, Howard K., et al.
Publicado: (2004) -
Gi/o-coupled muscarinic receptors co-localize with GIRK channel for efficient channel activation
por: Tateyama, Michihiro, et al.
Publicado: (2018) -
Biophysical Characterization of Epigallocatechin-3-Gallate Effect on the Cardiac Sodium Channel Na(v)1.5
por: Amarouch, Mohamed-Yassine, et al.
Publicado: (2020)